Salix Coronary Plaque vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary need is a detailed, AI-driven analysis of CCTA scans to comprehensively assess coronary artery disease. This tool is ideal for radiologists and cardiologists requiring precise quantification of plaque, identification of high-risk features, and stenosis assessment for advanced diagnostic insights from imaging data.
View Salix Coronary Plaque →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you require a rapid, non-invasive screening tool for early detection of low ejection fraction during routine physical exams. This AI algorithm, integrated with Eko digital stethoscopes, is best suited for primary care physicians and general practitioners seeking to quickly identify patients at risk for heart failure at the point of care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Subscription model | Unknown |
| Deployment | Cloud-based (Amazon Web Services), web-based software application | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) integrates seamlessly with Eko digital stethoscopes, providing results in approximately 15 seconds during a routine physical exam, which offers high accessibility and rapid point-of-care screening. While Salix Coronary Plaque is web-based and offers integrated workflow, CCTA analysis is a more involved diagnostic process. Tool B's integration into a routine physical exam makes it exceptionally user-friendly for a broad range of clinicians.
Clinical Value
Salix Coronary PlaqueSalix Coronary Plaque provides a highly detailed and comprehensive assessment of coronary artery disease from CCTA scans, including the detection and quantification of coronary plaque, identification of high-risk plaque features, and stenosis assessment. This offers deeper diagnostic insights for risk stratification and personalized treatment planning. While ELEFT provides valuable early detection of low ejection fraction, Salix's granular analysis of complex imaging data offers a more profound diagnostic contribution.
Pricing & Value
Salix Coronary PlaqueSalix Coronary Plaque explicitly states a per-scan assessment model with a US CPT reimbursement rate of US$950 per assessment, offering a clear and direct path for revenue generation and demonstrating tangible financial value for adopting institutions. Eko Low Ejection Fraction Tool's pricing is less transparent, being part of an enterprise platform with a 'contact for pricing' model, making its immediate financial return less clear without further inquiry.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool is explicitly stated to be part of Eko's SENSORAu2122 Cardiac Early Detection Platform, an enterprise solution, and confirms both BAA and HIPAA compliance. While Salix Coronary Plaque is cloud-deployed and web-based, suggesting enterprise capability, it does not explicitly state BAA or HIPAA compliance in the provided facts, giving Tool B a stronger position in this dimension.
Innovation
Salix Coronary PlaqueSalix Coronary Plaque demonstrates significant innovation by offering near real-time, AI-driven, detailed quantification and characterization of coronary plaque and high-risk features from CCTA scans, advancing beyond traditional stenosis assessment for more precise risk stratification. Eko Low Ejection Fraction Tool is innovative in integrating AI with a common stethoscope for early heart failure screening, but Salix's analytical depth in complex imaging data for advanced diagnostics represents a more profound innovation in diagnostic imaging.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health offers a comprehensive Help Center with readily available user manuals, FAQs, live Q&A sessions, 1:1 phone calls, email support, and a support ticket system, indicating robust and easily accessible support resources for ELEFT. While Artrya mentions a user guide and contact options for Salix Coronary Plaque, the breadth and detail of readily available support and documentation are more extensively documented for Eko Health.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | Salix Coronary Plaque | Eko Low Ejection Fraction Tool (ELEFT) |
| Primary Purpose | AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Core Functionality | AI-enabled CCTA analysis for detection and quantification of coronary plaque, high-risk plaque features, stenosis assessment, and calcium scoring. | AI-powered low ejection fraction detection by analyzing ECG and heart sound recordings, integrating with digital stethoscopes. |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Salix Coronary Plaque or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.